Skip to main content
. 2022 Dec 10;15(12):1536. doi: 10.3390/ph15121536

Figure 3.

Figure 3

Distribution of the number of reports of psychiatric adverse reactions analyzed for atorvastatin, rosuvastatin and simvastatin.